How Much Does the Moderna CEO Make?
Stephane Bancel, CEO of Moderna, earned $9.7M in total compensation in 2025, including $4.8M in stock awards and $966,000 in base salary.
This page answers a common executive-compensation question: How Much Does the Moderna CEO Make?. The answer draws on SEC DEF 14A proxy statements, the public disclosure mechanism for U.S. public-company executive pay. Every public company must file an annual proxy statement disclosing CEO and named-executive-officer compensation in detail. Why this matters for shareholders: executive compensation is the single most-disclosed governance metric at U.S. public companies, and the Dodd-Frank-mandated say-on-pay vote gives shareholders an explicit channel to express approval or dissent. Reading pay data well — including pay-versus-performance, peer-group selection, and time-vesting structures — is a basic part of stock-by-stock fundamental analysis.
The detailed answer below uses the actual proxy-statement filings, explains how to read them, and translates the executive-compensation accounting into the shareholder-relevant interpretation.
Stephane Bancel leads Moderna (MRNA), a Biotechnology company with approximately 5,700 employees. In the 2025 proxy statement filed with the SEC, Stephane Bancel's total compensation of $9,660,000 included $966,000 in base salary, $0 in cash bonus, $4,830,000 in stock awards, and $1,159,200 in option awards.
The CEO-to-median-worker pay ratio at Moderna is 77:1, meaning the CEO earns 77x the median worker's pay of $125,000. Over the past three years, Moderna produced a total shareholder return of 584.1% against 389.7% revenue growth. Our Pay-for-Performance Score rates the alignment as A (96/100).
In the most recent say-on-pay vote, 85.6% of shareholders approved the executive compensation plan. Moderate shareholder support suggests some investor concern with pay practices.
Key Data
| Component | Amount |
|---|---|
| Total Compensation | $9,660,000 |
| Base Salary | $966,000 |
| Stock Awards | $4,830,000 |
| Option Awards | $1,159,200 |
| Non-Equity Incentive | $1,449,000 |
| CEO-to-Worker Pay Ratio | 77:1 |
| Pay-Performance Grade | A |
Other Biotechnology CEOs
Frequently Asked Questions
Stephane Bancel, CEO of Moderna, earned $9.7M in total compensation in 2025, including $4.8M in stock awards and $966,000 in base salary.
Stephane Bancel is the chief executive officer of Moderna (MRNA).
The CEO at Moderna earns approximately 77 times the median worker's pay of $125,000.
In 2025, total compensation of $9,660,000 was composed of $966,000 base salary, $0 cash bonus, $4,830,000 stock awards, $1,159,200 option awards, and $1,449,000 in non-equity incentive compensation.
Our Pay-for-Performance Score rates Moderna as A (96/100), based on three-year total shareholder return of 584.1%, revenue growth of 389.7%, and shareholder say-on-pay vote approval.
Stephane Bancel, CEO of Moderna, earned $9.7M in total compensation in 2025, including $4.8M in stock awards and $966,000 in base salary.
Source: SEC EDGAR DEF 14A proxy statements, 2026.